![Stack of newspapers on a computer keyboard.](https://www.ppd.com/wp-content/uploads/2023/03/newspapers-keyboard_1447105652-1280x600.jpg)
In the News
Two Key Questions About Patient Experience in 2020
PM360 asked those with the know-how to improve the patient experience what the industry can do to better serve patients during and following the global pandemic.
![pm360 logo](https://www.ppd.com/wp-content/uploads/2019/12/pm360-e1578492774806.jpg)
Accessible Healthcare: The Key Role of Health Literacy
Health literacy can have a significant bearing on outcomes, so helping patients understand their health and treatments is critical.
![PharmaVoice logo](https://www.ppd.com/wp-content/uploads/2019/12/PharmaVoice-e1578492969283.jpg)
Global biotech: Leading health care innovation and how CROs are adapting to meet their needs
Davide Garrisi explains how clinical research organizations have created new models and resources to help biotech meet the global demand for innovative new options for patients.
![Contract Pharma](https://www.ppd.com/wp-content/uploads/2019/12/Contract-Pharma-e1578492947862.jpg)
The Future Face of Clinical Trials?
The pandemic’s impact is driving a new consensus that the need is now for expanded use of digitally enabled trials.
![](https://www.ppd.com/wp-content/uploads/2020/09/DDN-Logo.jpg)
Three NC life science execs crack PharmaVoice ‘most inspiring’ list
Leading life sciences magazine PharmaVoice has named three North Carolina executives to its list of the 100 most inspiring leaders in the pharmaceutical industry.
![techwire logo](https://www.ppd.com/wp-content/uploads/2019/12/WRALTechWire-SiteLogo.jpg)
Unleashing a Vision
For any other person, being president of one organization – Evidera – and being the chief medical officer of another – PPD – would be a full-time job. Yet, Karen Kaucic, MD excels in both positions.
![PharmaVoice logo](https://www.ppd.com/wp-content/uploads/2019/12/PharmaVoice-e1578492969283.jpg)
Predicting extractables and leachables from container stoppers
The authors discuss how data from migration kinetics studies can be used to develop models that predict levels of leachables and extractables at different temperatures and time points.
![BioPharm International](https://www.ppd.com/wp-content/uploads/2019/12/BioPharmInternationalLogo.jpg)
Advanced therapies: ‘Trip hazards’ on the development pathway
Kirsten Messmer and Richard Dennett discuss the development of advanced therapies and the challenges and complexities of getting them through the developmental pathway, which they call “the trip.”
![regulatory focus logo](https://www.ppd.com/wp-content/uploads/2020/01/reg-focus-final-e1578492744897.jpg)
Pfizer reups PPD deal in a contract research pact spree
PPD strategically positioned to continue supporting Pfizer in its pursuit of breakthroughs that change patients’ lives.
![Fierce Biotech](https://www.ppd.com/wp-content/uploads/2020/06/logo-biotech-thumbnail.jpg)